1. Levofloxacin is an intravenous antibiotic used to treat various bacterial infections.
2. AuroMedics initiated the recall after receiving a customer complaint of white particulate matter in the injection solution. The company tentatively identified the substance as mold.
3. Use of a nonsterile injection could cause serious or fatal infections in patients. However, AuroMedics has not received any reports of adverse events related to the recalled product.
4. The company is notifying its hospital customers of the recall and arranging for the return of all affected products.
More articles on supply chain:
Mylan reaffirms $1B share buyback plan
Dr. Reddy’s recalls 1k cancer drug vials over container defect: 4 things to know
6 must-reads for supply chain leaders
